Literature DB >> 18957893

Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells.

Li-Wen Ko1, Hwai-Hwa C Ko, Wen-Lang Lin, Jayanranyan G Kulathingal, Shu-Hui C Yen.   

Abstract

Filamentous alpha-synuclein (alpha-syn) aggregates form Lewy bodies (LBs), the neuropathologic hallmarks of Parkinson disease and related alpha-synucleinopathies. To model Lewy body-associated neurodegeneration, we generated transfectant 3D5 of human neuronal-type in which expression of human wild-type alpha-syn is regulated by the tetracycline off (TetOff)-inducible mechanism. Retinoic acid-elicited differentiation promoted assembly of alpha-syn aggregates after TetOff induction in 3D5 cells. The aggregates accumulated 14 days after TetOff induction were primarily soluble and showed augmented thioflavin affinity with concomitant phosphorylation and nitration of alpha-syn. Extension of the induction led to the formation of sarkosyl-insoluble aggregates that appeared concurrently with thioflavin-positive inclusions. Immunoelectron microscopy revealed that the inclusions consist of dense bundles of 8- to 12-nm alpha-syn fibrils that congregate in the perikarya and resemble Lewy bodies. Most importantly, accumulation of soluble and insoluble aggregates after TetOff induction for 14 and 28 days was reversible and did not compromise the viability of the cells or their subsequent survival. Thus, this chemically defined culture paradigm provides a useful means to elucidate how oxidative injuries and other insults that are associated with aging promote alpha-syn to self-assemble or interact with other molecules leading to neuronal degeneration in alpha-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957893      PMCID: PMC2768257          DOI: 10.1097/NEN.0b013e31818c3618

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  66 in total

1.  Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.

Authors:  Georgios M Hadjigeorgiou; Georgia Xiromerisiou; Vanessa Gourbali; Kostantinos Aggelakis; Nikolaos Scarmeas; Alexandros Papadimitriou; Andrew Singleton
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

2.  Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

Authors:  Kenya Nishioka; Shin Hayashi; Matthew J Farrer; Andrew B Singleton; Hiroyo Yoshino; Hisamasa Imai; Toshiaki Kitami; Kenichi Sato; Ryu Kuroda; Hiroyuki Tomiyama; Koichi Mizoguchi; Miho Murata; Tatsushi Toda; Issei Imoto; Johji Inazawa; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

3.  Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.

Authors:  Tomoaki Kamiyoshihara; Masaki Kojima; Kenji Uéda; Mitsuru Tashiro; Sakurako Shimotakahara
Journal:  Biochem Biophys Res Commun       Date:  2007-02-06       Impact factor: 3.575

4.  Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy.

Authors:  Li-Wen Ko; Jayanarayan G Kulathingal; Shu-Hui C Yen
Journal:  Neurochem Res       Date:  2006-12-06       Impact factor: 3.996

5.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

6.  Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

Authors:  George K Tofaris; Pablo Garcia Reitböck; Trevor Humby; Sarah L Lambourne; Mark O'Connell; Bernardino Ghetti; Helen Gossage; Piers C Emson; Lawrence S Wilkinson; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

7.  Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.

Authors:  Makio Takahashi; Li-wen Ko; Jayanarayan Kulathingal; Peizhou Jiang; Daniel Sevlever; Shu-Hui C Yen
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

8.  Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

Authors:  Michael L Kramer; Walter J Schulz-Schaeffer
Journal:  J Neurosci       Date:  2007-02-07       Impact factor: 6.167

9.  Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.

Authors:  Masaki Wakamatsu; Aiko Ishii; Yuriko Ukai; Junko Sakagami; Shingo Iwata; Mieko Ono; Kayo Matsumoto; Atsushi Nakamura; Norihiro Tada; Kazuto Kobayashi; Takeshi Iwatsubo; Makoto Yoshimoto
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

Review 10.  DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Authors:  C F Lippa; J E Duda; M Grossman; H I Hurtig; D Aarsland; B F Boeve; D J Brooks; D W Dickson; B Dubois; M Emre; S Fahn; J M Farmer; D Galasko; J E Galvin; C G Goetz; J H Growdon; K A Gwinn-Hardy; J Hardy; P Heutink; T Iwatsubo; K Kosaka; V M-Y Lee; J B Leverenz; E Masliah; I G McKeith; R L Nussbaum; C W Olanow; B M Ravina; A B Singleton; C M Tanner; J Q Trojanowski; Z K Wszolek
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

View more
  28 in total

1.  Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity.

Authors:  Yuka E Lewis; Tharindumala Abeywardana; Yu Hsuan Lin; Ana Galesic; Matthew R Pratt
Journal:  ACS Chem Biol       Date:  2016-01-12       Impact factor: 5.100

2.  Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1alpha enhances alpha-synuclein oligomerization and down regulates AKT/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein.

Authors:  Abdul Shukkur Ebrahim; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2010-02-21       Impact factor: 3.046

Review 3.  Prion-Like Characteristics of Polyglutamine-Containing Proteins.

Authors:  Margaret M P Pearce; Ron R Kopito
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

4.  Histones facilitate α-synuclein aggregation during neuronal apoptosis.

Authors:  Peizhou Jiang; Ming Gan; Shu-Hui Yen; Pamela J McLean; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2016-12-21       Impact factor: 17.088

5.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

6.  The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.

Authors:  Ossama Khalaf; Bruno Fauvet; Abid Oueslati; Igor Dikiy; Anne-Laure Mahul-Mellier; Francesco Simone Ruggeri; Martial K Mbefo; Filip Vercruysse; Giovanni Dietler; Seung-Jae Lee; David Eliezer; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

7.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

8.  Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites.

Authors:  Peizhou Jiang; Ming Gan; Abdul Shukkur Ebrahim; Monica Castanedes-Casey; Dennis W Dickson; Shu-Hui C Yen
Journal:  Neurobiol Aging       Date:  2012-11-28       Impact factor: 4.673

9.  Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process.

Authors:  Chai-Jui Tsai; Kiran Aslam; Holli M Drendel; Josephat M Asiago; Kourtney M Goode; Lake N Paul; Jean-Christophe Rochet; Tony R Hazbun
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

10.  The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Authors:  Mohamed-Bilal Fares; Nadine Ait-Bouziad; Igor Dikiy; Martial K Mbefo; Ana Jovičić; Aoife Kiely; Janice L Holton; Seung-Jae Lee; Aaron D Gitler; David Eliezer; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.